UNC Lineberger News

Marks talks about newest radiation treatment and what it offers

Marks talks about newest radiation treatment and what it offers

Lawrence Marks, MD, chair of UNC's department of radiation oncology and a UNC Lineberger member, is quoted in the article "TomoTherapy offers safer radiation" published in today's issue of The News & Observer.

Marks talks about newest radiation treatment and what it offers - Read More…

N.C. Cancer Hospital on “Great Oncology Program” list

Becker's Hospital Review has named the N.C Cancer Hospital as one of "70 Hospitals with Great Oncology Programs."

N.C. Cancer Hospital on “Great Oncology Program” list - Read More…

Triangle Bladder Cancer Support Group: Here to Help

Triangle Bladder Cancer Support Group: Here to Help

Bladder cancer patients in the Triangle area are not alone. They have a monthly group where “true loving support for each other” is shared, says David Langham, a bladder cancer survivor and one of the organizers of the group.

Triangle Bladder Cancer Support Group: Here to Help - Read More…

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded

The way tobacco products are marketed and sold changed with the June 2009 passage of the Family Smoking Prevention and Tobacco Control Act. For example, this law mandates larger and stronger warning labels on packs and advertising and prohibits the sale of “light” and clove cigarettes. The FDA Act also now allows states and local communities to regulate the time, place, and manner of tobacco advertising. Thus, states could restrict tobacco promotions or restrict the location of tobacco advertising.

UNC and partners to study policies to restrict tobacco marketing at point of sale: multi-institutional $6.7 million research grant awarded - Read More…

UNC scientists collaborate on colon cancer therapy comparative effectiveness study

UNC scientists collaborate on colon cancer therapy comparative effectiveness study

In 2008 UNC and Harvard University’s Brigham and Women’s Hospital in Boston were selected by the U.S. Agency for Healthcare Research and Quality to carry out accelerated practical studies examining the comparative effectiveness of cancer treatments. The collaboration is called the Cancer Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Comparative Effectiveness Consortium.

UNC scientists collaborate on colon cancer therapy comparative effectiveness study - Read More…

Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting

As part of Patient Power® coverage of the annual meeting of the American Society of Hematology (ASH), UNC Lineberger member Steven Park, MD, talks about the latest in treatment for Hodgkin Lymphoma.

Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting - Read More…

real doctors, real people - Paul Godley

Whether photographing a child in the streets of Vietnam or consulting with a patient about a diagnosis, Dr. Paul Godley employs his intuition and charming personality to put the person in front of him at ease within a matter of moments.

real doctors, real people - Paul Godley - Read More…